Award
National Institute of Allergy and Infectious Diseases 5R01AI183539-02
Self Assembled Peptide Nanoparticles as Multi-Antigen Universal Influenza Vaccines
Recipient
Georgia Institute of Technology
Award Amount
$376,592.00
Ceiling
$376,592.00
Awarded
June 19, 2026
Identifier
5R01AI183539-02
The award supports research on self-assembled peptide nanocages as a universal influenza vaccine platform to improve broad and long-term protection against flu viruses by presenting multiple conserved antigens.
Description
This project aims to develop a universal influenza vaccine platform using self-assembled peptide nanocages, with a focus on broad protection and long-term efficacy. The work will evaluate and enhance the broad vaccine effectiveness of nanocages presenting multiple conserved influenza antigens.